TIAM1 and prostate carcinoma: Moreover, Kaplan–Meier analysis showed that prostate cancer patients with pT3 stage and GS⩾7, respectively, could be further classified based on the extent of Tiam1 overexpression in their prostate cancer specimens to predict disease recurrence more accurately.